Javelin Biotech ^Companies

Javelin Biotech is a predictive drug discovery platform that combines human biology with computational biology to accelerate preclinical drug discovery and improve drug approval rates. Their goal is to develop safe and efficacious therapies by understanding the interactions between drugs and human physiology. They address the limitations of current preclinical testing models by using human tissue chips that generate longitudinal, high-content, and human-relevant data. Javelin's AI-enabled digital twin technology analyzes this data to design better medicines faster. Their approach aims to reduce preclinical drug discovery costs and minimize the risk of clinical attritions.